Drugs, driving and traffic safety in allergic rhinitis

Drugs, Driving and Traffic Safety

Volumn , Issue , 2009, Pages 371-381

  Theunissen, Eef Lien ^a   Vermeeren, Annemiek ^a   Vuurman, Eric F P M ^a   Ramaekers, Johannes G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349664986     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-7643-9923-8_23     Document Type: Chapter

References (42)

1. Steerenberg PA, Van Loveren H, Vandebriel F J, Vos JG, Opperhuizen A, Van Amsterdam JGC (2000) The prevalence of asthma and allergy increases: a world-wide problem. Rijksinstituut voor volksgezondheid en milieu, Bilthoven, 1-30
2. Nathan RA, Meltzer EO, Seiner JC, Storms W (1997) Prevalence of allergic rhinitis in the United States. Journal of Allergy and Clinical Immunology 99, S808-S814
3. Snyder SH, Snowman AM (1987) Receptor effects of cetirizine. Ann Allergy 59:4-8
4. Simons FE (1989) Hl-receptor antagonists: clinical pharmacology and therapeutics. Journal of Allergy and Clinical Immunology 84:845-861
5. Golightly LK, Greos LS (2005) Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Drugs 65:341-384
6. Simons FE, Simons KJ, Chung M, Yeh J (1987) The comparative pharmacokinetics of Hlreceptor antagonists. Ann Allergy 59:20-24.
7. Gonzalez MA, Estes KS (1998) Pharmacokinetic overview of oral second-generation HI antihistamines. International Journal of Clinical Pharmacology and Therapeutics 36:292-300
8. Slater JW, Zechnich AD, Haxby DG (1999) Second-generation antihistamines: a comparative review. Drugs 57:31-47
9. Nicholson AN, Pascoe PA, Turner C, Ganellin CR, Greengrass PM, Casy AF, Mercer AD (1991) Sedation and histamine Hl-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. British Journal of Pharmacology 104:270-276
10. Quach TT, Duchemin AM, Rose C, Schwartz JC (1979) In vivo occupation of cerebral histamine HI-receptors evaluated with 3H-mepyramine may predict sedative properties of psychotropic drugs. European Journal of Pharmacology 60:391-392
11. Rose C, Quach TT, Llorens C, Schwartz JC (1982) Relationship between occupation of cerebral HI-receptors and sedative properties of antihistamines. Assessment in the case of terfenadine. Arzneimittel Forschung 32:1171-1173
12. Tagawa M, Kano M, Okamura N, Higuchi M, Matsuda M, Mizuki Y, Arai H, Iwata R, Fujii T, Komemushi S et al (2001) Neuroimaging of histamine Hl-receptor occupancy in human brain by positron emission tomography (PET): a comparative study of ebastine, a second-generation antihistamine, and (+ Chlorpheniramine, a classical antihistamine. British Journal of Clinical Pharmacology 52:501-509
13. Tashiro M, Mochizuki H, Iwabuchi K, Sakurada Y, Itoh M, Watanabe T, Yanai K (2002) Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine HI receptors in human brain. Life Sciences 72:409-414
14. Burton WN, Conti DJ, Chen CY, Schultz AB, Edington DW (2001) The impact of allergies and allergy treatment on worker productivity. Journal of Occupational and Environmental Medicine 43:64-71
15. McLoughlin J, Nail M, Isaacs B, Petrosko J, Karibo J, Lindsey B (1983) The relationship of allergies and allergy treatment to school performance and student behavior. Annals of Allergy 51:506-510
16. McMenamin P (1994) Costs of hay fever in the United States in 1990. Annals of Allergy 73:35-39
17. Cimbura G, Lucas DM, Bennett RC, Warren RA, Simpson HM (1982) Incidence and toxicological aspects of drugs detected in 484 fatally injured drivers and pedestrians in Ontario. Journal of Forensic Sciences 27:855-867
18. Ray WA, Fought RL, Decker MD (1992) Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers. American Journal of Epidemiology 136:873-883.
19. Leveille SG, Buchner DM, Koepsell TD, McCloskey LW, Wolf ME, Wagner EH (1994) Psychoactive medications and injurious motor vehicle collisions involving older drivers. Epidemiology 5:591-598.
20. Gilmore TM, Alexander BH, Mueller BA, Rivara FP (1996) Occupational injuries and medication use. American Journal of Industrial Medicine 30:234-239
21. Passalacqua G, Bousquet J, Bachert C, Church MK, Bindsley-Jensen C, Nagy L, Szemere P, Davies RJ, Durham SR, Horak F et al (1996) The clinical safety of Hl-receptor antagonists. An EAACI position paper. Allergy 51:666-675
22. Mann RD, Pearce GL, Dunn N, Shakir S (2000) Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice. British Medical Journal 320:1184-1186.
23. Casale TB, Blaiss MS, Gelfand E, Gilmore T, Harvey PD, Hindmarch I, Simons FE, Spangler DL, Szefler SJ, Terndrup TE et al (2003) First do no harm: managing antihistamine impairment in patients with allergic rhinitis. Journal of Allergy and Clinical Immunology 111, S835-842
24. Vermeeren A, Ramaekers JG, O'Hanlon JF (2002) Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females. Journal of Psychopharmacology 16:57-64
25. Vuurman EF, Theunissen EL, Oers ACM, Leeuwen, Mies J (2007) Lack of effects between rupatadine lOmg and placebo on actual driving performance of healthy volunteers. Human Psychopharmacology 22:289-297
26. Ramaekers JG, O'Hanlon JF (1994) Acrivastine, terfenadine and diphenhydramine effects on driving performance as a function of dose and time after dosing. European Journal of Clinical Pharmacology 47:261-266
27. Vuurman EFPM, Rikken GH, Muntjewerff ND, De Halleux F, Ramaekers JG (2004) Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements. European Journal of Clinical Pharmacology 60:307-313
28. Verster JC, De Weert AM, Bijtjes SI, Aarab M, Van Oosterwijck AW, Eijken EJ, Verbaten MN, Volkerts ER (2003) Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial. Psychopharmacology 169:84-90
29. Vuurman EF, Uiterwijk MM, Rosenzweig P, O'Hanlon JF (1994) Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. European Journal of Clinical Pharmacology 47:253-259
30. Vermeeren A, O'Hanlon JF (1998) Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performance. Journal of Allergy and Clinical Immunology 101:306-311
31. Volkerts ER, Van Willigenburg AP, Van Laar MW, Maes RA (1992) Does cetirizine belonto the new generation of antihistamines? An investigation into its acute and subchronic effects on highway driving, psychometric test performance and daytime sleepiness. Human Psychopharmacology Clinical and Experimental 7:227-238
32. Robbe HWJ, O'Hanlon JF (1990) Effects of acrivastine, acrivastine plus pseudoephedrine and triprolidine on highway driving. Institute for Drugs, Safety and Behavior University of Limburg, Maastricht
33. Riedel WJ, Ramaekers G, Uiterwijk MM, O'Hanlon JF (1990) Higher doses of terfenadine and loratadine: acute and subchronic effects on psychomotor and actual driving performance. Institute for Drugs, Safety and Behavior, University of Limburg, Maastricht, IGVG 90-12
34. De Vries G, De Waard D, Brookhuis KA (1989) A double blind study to compare the acute and subchronic effects of ebastine 10, 20, 30 mg o.d., triprolidine 10 mg o.d. and placebo on car driving performance. Traffic Research Center University of Groningen, Groningen
35. Riedel WJ, Schoenmakers EAJM, O'Hanlon JF (1989) Sedation and performance impairment with antihistamines. In: MAKalinger (ed): Management of allergy in the 1990s. Hans Huber, Toronto, 38-49
36. Theunissen EL, Vermeeren A, Van Oers ACM, Van Maris I, Ramaekers JG (2004) A dose ranging study of the effects of mequitazine on actual driving, memory and psychomotor performance as compared to dexchlorpheniramine, cetirizine and placebo. Clinical and Experimental Allergy 34:250-258
37. Theunissen EL, Vermeeren A, Ramaekers JG (2006) Repeated-dose effects of mequitazine, cetirizine and dexchlorpheniramine on driving and psychomotor performance. British Journal of Clinical Pharmacology 61:79-86
38. Ramaekers JG, Uiterwijk MM, O'Hanlon JF (1992) Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during driving. European Journal of Clinical Pharmacology 42:363-369
39. Taglialatela M, Timmerman H, Annuziato L (2000) Cardiotoxic potential and CNS effects of first-generation antihistamines. Trends-in-pharmacological- sciences 21:52-56
40. O'Hanlon JF, Ramaekers JG (1995) Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989-94. Allergy 50:234-342
41. Verster JC, Volkerts ER, Van Oosterwijck AW, Aarab M, Bijtjes SI, De Weert AM, Eijken EJ, Verbaten MN (2003) Acute and subchronic effects of levocetirizine and diphenhydramine on memory functioning, psychomotor performance, and mood. Journal of Allergy and Clinical Immunology 111:623-627
42. Louwerens JW, Gloerich ABM, De Vries G, Brookhuis KA, O'Hanlon JF (1987) The relationship between driver's blood alcohol concentration (BAC) and actual driving performance during high speed travel. In: PC Noordzij, R Roszbach (eds.) International congress on alcohol, drugs and traffic safety, T 86. Exerpta Medica, Amsterdam, 183-186